| 1 |
Hematologic adverse effects induced by piperacillin–tazobactam: a systematic review of case reports |
|
| | Qingqing Wang, Zhongfang He, Xin’an Wu, Yuhui Wei, Jianlin Huang | | | International Journal of Clinical Pharmacy. 2020; 42(4): 1026 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Higher Risk of Neutropenia Associated With Piperacillin-Tazobactam Compared With Ticarcillin-Clavulanate in Children |
|
| | P. Lemieux,J.-P. Gregoire,R. Thibeault,L. Bergeron | | | Clinical Infectious Diseases. 2014; | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Systematic Review of Piperacillin-Induced Neutropenia |
|
| | Marc H Scheetz,June M McKoy,Jorge P Parada,Benjamin Djulbegovic,Dennis W Raisch,Paul R Yarnold,Jessica Zagory,Steve Trifilio,Rita Jakiche,Frank Palella,Adam Kahn,Kevin Chandler,Charles L Bennett | | | Drug Safety. 2007; 30(4): 295 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Systematic review of piperacillin-induced neutropenia |
|
| | Scheetz, M.H., McKoy, J.M., Parada, J.P., Djulbegovic, B., Raisch, D.W., Yarnold, P.R., Zagory, J., (...), Bennett, C.L. | | | Drug Safety. 2007; 30(4): 295-306 | | | [Pubmed] [Google Scholar] | |
|
